Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC). (June 2018)
- Record Type:
- Journal Article
- Title:
- Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC). (June 2018)
- Main Title:
- Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
- Authors:
- Tsiachristas, Apostolos
Gittins, Matthew
Kitchener, Henry
Gray, Alastair - Abstract:
- Objective: To assess the cost-effectiveness of strategies to increase cervical cancer screening uptake at first invitation (STRATEGIC trial). Methods: We performed an economic analysis alongside the STRATEGIC trial, comparing each of seven novel interventions for improving cervical screening uptake with control general practices in Greater Manchester and Grampian (United Kingdom). A template was developed to measure the intervention costs. Trial estimates of screening uptake were combined with data from the literature to estimate healthcare costs of each intervention. The added lifetime costs and quality adjusted life years (QALYs) of attending cervical screening were estimated by a systematic literature review, with relevant results pooled and weighted by study quality. Trial results and estimated lifetime costs and benefits of screening were then combined in a decision analytic model, giving an incremental cost per QALY gained for each intervention. Uncertainty was addressed in probabilistic and univariate sensitivity analyses. Results: Intervention costs per screening round per woman attending varied from about £1.20 (2014 UK) for the nurse navigator intervention to £62 for the unrequested HPV self-sampler kit. The meta-analysis revealed a lifetime discounted benefit from screening of 0.043 QALYs per woman attending, at an additional lifetime discounted cost of £234. The incremental cost per QALY gained in all interventions was below £13, 000. Probabilistic sensitivityObjective: To assess the cost-effectiveness of strategies to increase cervical cancer screening uptake at first invitation (STRATEGIC trial). Methods: We performed an economic analysis alongside the STRATEGIC trial, comparing each of seven novel interventions for improving cervical screening uptake with control general practices in Greater Manchester and Grampian (United Kingdom). A template was developed to measure the intervention costs. Trial estimates of screening uptake were combined with data from the literature to estimate healthcare costs of each intervention. The added lifetime costs and quality adjusted life years (QALYs) of attending cervical screening were estimated by a systematic literature review, with relevant results pooled and weighted by study quality. Trial results and estimated lifetime costs and benefits of screening were then combined in a decision analytic model, giving an incremental cost per QALY gained for each intervention. Uncertainty was addressed in probabilistic and univariate sensitivity analyses. Results: Intervention costs per screening round per woman attending varied from about £1.20 (2014 UK) for the nurse navigator intervention to £62 for the unrequested HPV self-sampler kit. The meta-analysis revealed a lifetime discounted benefit from screening of 0.043 QALYs per woman attending, at an additional lifetime discounted cost of £234. The incremental cost per QALY gained in all interventions was below £13, 000. Probabilistic sensitivity analyses suggested that only unrequested self-sampling and timed appointments have a high probability of being cost-effective. Conclusions: Unrequested self-sampling and timed appointments are likely to be cost-effective interventions. Further research is required on the duration of effects and on implementing combinations of interventions. … (more)
- Is Part Of:
- Journal of medical screening. Volume 25:Number 2(2018)
- Journal:
- Journal of medical screening
- Issue:
- Volume 25:Number 2(2018)
- Issue Display:
- Volume 25, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 25
- Issue:
- 2
- Issue Sort Value:
- 2018-0025-0002-0000
- Page Start:
- 99
- Page End:
- 109
- Publication Date:
- 2018-06
- Subjects:
- Cost-effectiveness -- screening uptake -- cervical cancer -- United Kingdom
Medical screening -- Periodicals
362.177 - Journal URLs:
- https://journals.sagepub.com/home/msca ↗
http://jms.rsmjournals.com ↗
http://msc.sagepub.com ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/0969141317704679 ↗
- Languages:
- English
- ISSNs:
- 0969-1413
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8420.xml